Protalix BioTherapeutics Inc (PLX)
1.38
-0.03
(-2.13%)
USD |
NYAM |
Nov 15, 12:34
Protalix BioTherapeutics Net Income (TTM): -14.69M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -14.69M |
| March 31, 2024 | 6.848M |
| December 31, 2023 | 8.312M |
| September 30, 2023 | 10.62M |
| June 30, 2023 | 8.901M |
| March 31, 2023 | -15.77M |
| December 31, 2022 | -14.93M |
| September 30, 2022 | -17.85M |
| June 30, 2022 | -18.49M |
| March 31, 2022 | -24.39M |
| December 31, 2021 | -27.58M |
| September 30, 2021 | -20.52M |
| June 30, 2021 | -20.76M |
| March 31, 2021 | -13.66M |
| December 31, 2020 | -6.523M |
| September 30, 2020 | -6.629M |
| June 30, 2020 | -5.752M |
| March 31, 2020 | -9.345M |
| December 31, 2019 | -18.28M |
| September 30, 2019 | -24.00M |
| June 30, 2019 | -25.76M |
| March 31, 2019 | -26.48M |
| December 31, 2018 | -26.46M |
| September 30, 2018 | -34.33M |
| June 30, 2018 | -40.44M |
| Date | Value |
|---|---|
| March 31, 2018 | -31.53M |
| December 31, 2017 | -83.44M |
| September 30, 2017 | -72.76M |
| June 30, 2017 | -68.61M |
| March 31, 2017 | -79.92M |
| December 31, 2016 | -29.36M |
| September 30, 2016 | 46.16M |
| June 30, 2016 | 49.63M |
| March 31, 2016 | 55.41M |
| December 31, 2015 | 58.04M |
| September 30, 2015 | -23.33M |
| June 30, 2015 | -27.52M |
| March 31, 2015 | -28.57M |
| December 31, 2014 | -29.94M |
| September 30, 2014 | -32.36M |
| June 30, 2014 | -30.10M |
| March 31, 2014 | -30.81M |
| December 31, 2013 | -27.79M |
| September 30, 2013 | -26.78M |
| June 30, 2013 | -26.51M |
| March 31, 2013 | -10.04M |
| December 31, 2012 | -11.62M |
| September 30, 2012 | -10.65M |
| June 30, 2012 | -14.05M |
| March 31, 2012 | -37.38M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-27.58M
Minimum
Dec 2021
10.62M
Maximum
Sep 2023
-10.55M
Average
-14.69M
Median
Jun 2024
Net Income (TTM) Benchmarks
| Accuray Inc | -16.53M |
| Aethlon Medical Inc | -11.50M |
| Predictive Oncology Inc | -14.04M |
| bluebird bio Inc | -311.44M |
| AIM ImmunoTech Inc | -28.04M |